Replacing the stethoscope.

We want to revolutionise screening for disease with novel medical devices and machine learning. Our goal is to transform lives by providing early detection of disease to everyone.

The stethoscope is an outdated tool.

Abnormal sounds are the first warning sign for many diseases in the heart, lungs and other organs. For the past 200 years medicine has relied on a doctor using a stethoscope to interpret the sounds and produce a diagnosis.

This is time-consuming and inaccurate. Diagnoses are being missed and healthcare is being overburdened.

We want to change this.

Valvular heart disease is the next cardiac epidemic.

Heart valve disease is the most common heart disease detected with a stethoscope.

Nearly two million people in the UK have significant valvular heart disease. Less than half of them are diagnosed. As our population ages, the burden will double by 2050.

By the time severe symptoms present, patients die within two to five years.

We need a new solution to prevent life-limiting symptoms and sudden cardiac death.

Our solution

A simple, accessible screening tool for valvular heart disease.

z

Novel acoustic hardware

A novel medical device that replaces the stethoscope in recording sounds from the body. Not just a tool for doctors but designed to be accessible to any healthcare professional.

T

AI-driven diagnoses

By using state-of-the-art machine learning techniques, we can automatically analyse sound recordings to predict the presence of clinically significant disease accurately. Our software completely removes the skill barrier to interpreting the sounds heard while providing greater accuracy than a GP with many years of experience.

Our models are trained and evaluated on our world-leading datasets consisting of thousands of recordings from actual NHS patients with valvular heart disease.

About us

We are a spin-out from the University of Cambridge Acoustics Lab. We are a team of engineers, machine learning experts and experienced clinicians who are all passionate about transforming patient lives by improving early detection of disease across the world.

Core Team

Dr. Andrew McDonald

Dr. Andrew McDonald

CEO & Co-Founder

Research Associate, Acoustics and Machine Learning, University of Cambridge.

Prof. Anurag Agarwal

Prof. Anurag Agarwal

CSO & Co-Founder

Professor of Acoustics and Biomedical Engineering, University of Cambridge.

Prof. Rick Steeds

Prof. Rick Steeds

Chief Medical Advisor

Consultant Cardiologist and Deputy Director of Clinical Research, ICVS Birmingham.

Prof. Steve Young CBE FRS FREng

Prof. Steve Young CBE FRS FREng

Chairman

Emeritus Professor, University of Cambridge. Entrepreneur and investor.

Selected Advisors

Prof. Mark Gales

Prof. Mark Gales

Professor of Information Engineering, University of Cambridge.

Dr. Katja Kostelnik

Dr. Katja Kostelnik

Commercialisation Manager, Cambridge Enterprise.

Dr. Girish Sabnis

Dr. Girish Sabnis

Cardiologist, King Edwards Hospital Mumbai.

Dr. Bushra Rana

Dr. Bushra Rana

Consultant Cardiologist, Imperial College London.

Andrew Hatcher

Andrew Hatcher

Entrepreneur, Judge Business School advisor, and investor.

Latest news

Papworth Hospital AI study could detect early heart valve disease

BBC Look East highlighting our research in collaboration with the Royal Papworth Hospital and other NHS cardiac centres.

Full article (bbc.co.uk)

Collaboration with 'Your Heart Matters' screening bus event in Birmingham

Technology shown to clinicians and general public to help raise awareness of valve disease.

Further details (heartvalvevoice.com)

Demonstrated to MPs at Heart Valve Awareness event in Westminster

Machine learning technology shown to MPs  at a parliamentary event in Portcullis House, hosted by MP Steve McCabe.

Video of the day (YouTube)

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.